Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1702) 1702
Newsletter (31) 31
Book Chapter (27) 27
Magazine Article (11) 11
Newspaper Article (7) 7
Dissertation (4) 4
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1329) 1329
science & technology (1220) 1220
life sciences & biomedicine (1198) 1198
itraconazole (1020) 1020
male (786) 786
antifungal agents - therapeutic use (780) 780
female (704) 704
itraconazole - therapeutic use (695) 695
adult (539) 539
middle aged (527) 527
biological and medical sciences (483) 483
medical sciences (477) 477
antifungal agents - adverse effects (436) 436
itraconazole - adverse effects (398) 398
itraconazole - administration & dosage (390) 390
antifungal agents - administration & dosage (377) 377
pharmacology. drug treatments (338) 338
infectious diseases (336) 336
antifungal agents (332) 332
aged (330) 330
pharmacology & pharmacy (313) 313
treatment outcome (308) 308
dermatology (280) 280
mycoses (270) 270
drug interactions (252) 252
antibiotics. antiinfectious agents. antiparasitic agents (241) 241
administration, oral (230) 230
fluconazole (211) 211
adolescent (209) 209
voriconazole (175) 175
microbiology (166) 166
animals (161) 161
amphotericin b - therapeutic use (160) 160
fluconazole - therapeutic use (153) 153
itraconazole - pharmacology (151) 151
drug therapy (147) 147
aspergillosis - drug therapy (144) 144
terbinafine (138) 138
mycoses - drug therapy (136) 136
onychomycosis - drug therapy (136) 136
child (135) 135
health aspects (133) 133
antifungal agents - pharmacology (132) 132
care and treatment (131) 131
abridged index medicus (127) 127
medicine & public health (125) 125
immunology (120) 120
ketoconazole - therapeutic use (119) 119
amphotericin b (117) 117
antifungal agents - pharmacokinetics (115) 115
drug therapy, combination (113) 113
mycoses - prevention & control (112) 112
mycology (105) 105
onychomycosis (104) 104
transplantation (104) 104
human mycoses (103) 103
itraconazole - pharmacokinetics (103) 103
general & internal medicine (101) 101
fungal infections (100) 100
posaconazole (100) 100
analysis (97) 97
drug administration schedule (97) 97
risk factors (95) 95
ketoconazole - analogs & derivatives (94) 94
aspergillosis (91) 91
immunocompromised host (91) 91
medicine, general & internal (91) 91
young adult (90) 90
research (88) 88
naphthalenes - therapeutic use (86) 86
oncology (85) 85
retrospective studies (85) 85
fungi (82) 82
internal medicine (81) 81
pharmacokinetics (81) 81
prospective studies (81) 81
dermatomycoses - drug therapy (78) 78
triazoles - therapeutic use (78) 78
dosage and administration (76) 76
patients (76) 76
pharmacology/toxicology (76) 76
veterinary sciences (76) 76
infections (75) 75
ketoconazole - adverse effects (74) 74
dose-response relationship, drug (73) 73
ketoconazole (72) 72
aged, 80 and over (68) 68
follow-up studies (68) 68
double-blind method (67) 67
drugs (65) 65
candidiasis - drug therapy (64) 64
hematology (64) 64
amphotericin b - administration & dosage (63) 63
child, preschool (63) 63
microbial sensitivity tests (62) 62
itraconazole - blood (61) 61
pediatrics (61) 61
surgery (60) 60
cancer (59) 59
complications and side effects (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1687) 1687
Japanese (29) 29
French (22) 22
German (22) 22
Spanish (22) 22
Chinese (12) 12
Dutch (11) 11
Portuguese (11) 11
Korean (4) 4
Russian (4) 4
Finnish (3) 3
Italian (3) 3
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Update on rifampin, rifabutin, and rifapentine drug interactions
by Baciewicz, Anne M and Chrisman, Cary R and Finch, Christopher K and Self, Timothy H
Current medical research and opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Rifabutin | Rifampin | Rifapentine | Drug interactions | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Pharmacology. Drug treatments | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The investigational drug VT-1129 is a highly potent inhibitor of Cryptococcus species CYP51 but only weakly inhibits the human enzyme
by Warrilow, Andrew G. S and Parker, Josie E and Price, Claire L and Nes, W. David and Garvey, Edward P and Hoekstra, William J and Schotzinger, Robert J and Kelly, Diane E and Kelly, Steven L
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 08/2016, Volume 60, Issue 8, pp. 4530 - 4538
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Cryptococcus - metabolism | Antifungal Agents - adverse effects | Fluconazole - pharmacology | Tetrazoles - pharmacology | Ergosterol - metabolism | Voriconazole - adverse effects | Voriconazole - pharmacology | Humans | Clotrimazole - pharmacology | Fluconazole - adverse effects | Lanosterol - analogs & derivatives | Enzyme Activation - drug effects | Itraconazole - pharmacology | Ketoconazole - pharmacology | Pyridines - adverse effects | Clotrimazole - adverse effects | Itraconazole - adverse effects | Lanosterol - metabolism | Pyridines - pharmacology | Sterol 14-Demethylase - metabolism | Ketoconazole - adverse effects | Tetrazoles - adverse effects | Cryptococcus - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
by Awotiwon, Ajibola A and Johnson, Samuel and Rutherford, George W and Meintjes, Graeme and Eshun‐Wilson, Ingrid and Awotiwon, Ajibola A
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, pp. CD004773 - CD004773
HIV/AIDS | Primary Prevention | Fluconazole | HIV Seropositivity | Cryptococcosis | Other complications/co‐morbidities: treatment | CD4 Lymphocyte Count | Cause of Death | Randomized Controlled Trials as Topic | Prevention | Infectious disease | HIV | AIDS‐Related Opportunistic Infections | Candida | Antifungal Agents | Prevention: other | Medicine General & Introductory Medical Sciences | Drug Resistance, Fungal | Itraconazole | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antifungal Agents - adverse effects | HIV Seropositivity - complications | Cryptococcosis - prevention & control | Humans | Fluconazole - adverse effects | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | AIDS-Related Opportunistic Infections - prevention & control | Itraconazole - adverse effects | Cryptococcosis - mortality | Adult | Candida - drug effects | Child | HIV Seropositivity - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis
by Le, Thuy and Kinh, Nguyen Van and Cuc, Ngo T.K and Tung, Nguyen L.N and Lam, Nguyen T and Thuy, Pham T.T and Thuy, Tran P and Cuong, Do D and Phuc, Pham T.H and Vinh, Vu H and Hanh, Doan T.H and Tam, Vu Van and Thanh, Nguyen T and Hang, Nguyen T and Long, Hoang B and Nhan, Ho T and Wertheim, Heiman F.L and Merson, Laura and Shikuma, Cecilia and Day, Jeremy N and Chau, Nguyen V.V and Farrar, Jeremy and Thwaites, Guy and Wolbers, Marcel and IVAP Investigators
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 24, pp. 2329 - 2340
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antifungal Agents - adverse effects | Administration, Oral | Humans | AIDS-Related Opportunistic Infections - drug therapy | Deoxycholic Acid - therapeutic use | Male | Antifungal Agents - therapeutic use | Induction Chemotherapy - adverse effects | Amphotericin B - adverse effects | Itraconazole - therapeutic use | Creatinine - metabolism | Deoxycholic Acid - adverse effects | Itraconazole - adverse effects | AIDS-Related Opportunistic Infections - mortality | Infusions, Intravenous - adverse effects | Mycoses - drug therapy | Talaromyces - isolation & purification | Adult | Female | Mycoses - mortality | Amphotericin B - therapeutic use | Drug Combinations | Usage | Care and treatment | Amphotericin B | HIV patients | Drug therapy | HIV infection | Itraconazole | Intravenous administration | Kidneys | Anemia | Mortality | Body weight | Immune clearance | Clinical trials | Immune reconstitution | Inflammation | Fungal infections | Side effects | Fungicidal activity | Human immunodeficiency virus--HIV | Renal failure | Hypokalemia | Hypomagnesemia | Pharmaceuticals | Kidney transplantation | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
by Benitez, Lydia L and Carver, Peggy L
Drugs (New York, N.Y.), ISSN 0012-6667, 06/2019, Volume 79, Issue 8, pp. 833 - 853
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Fungicides | Transplants & implants | Fluorine | Liver | Prophylaxis | Systematic review | Fungal infections | Cancer therapies | Hematopoietic stem cells | Skin cancer | Pain | Heterocyclic compounds | Voriconazole | Hypokalemia | Hepatotoxicity | Drug dosages | Itraconazole | Gynecomastia | Squamous cell carcinoma | Hyponatremia | Baldness | Invasiveness | Antifungal agents | Pancreatitis | Fluorides | Metabolism | Hemopoiesis | Azoles | Periostitis | Alopecia | Stem cells | Posaconazole
Journal Article
Details down arrow
6. Full Text Drug-induced heart failure
by Carleton B. Maxwell and Antoine T. Jenkins
American journal of health-system pharmacy, ISSN 1079-2082, 10/2011, Volume 68, Issue 19, pp. 1791 - 1804
Antifungals | Heart failure | Immunomodulating agents | Postmarketing surveillance | Toxicity | Antineoplastic agents | Cardiac drugs | Dronedarone | Tyrosine kinase inhibitors | Bevacizumab | Dutasteride | Lapatinib | Thiazolidinediones | Itraconazole | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antifungal Agents - adverse effects | Appetite Depressants - adverse effects | Calcium Channel Blockers - adverse effects | Humans | Thiazolidinediones - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Arrhythmia Agents - adverse effects | Antineoplastic Agents - adverse effects | Pharmacy Service, Hospital | Biological Products - adverse effects | Pharmacists | Hypoglycemic Agents - adverse effects | Glucocorticoids - adverse effects | Heart Failure - chemically induced | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Development and progression | Dosage and administration | Nonsteroidal anti-inflammatory drugs | Diagnosis | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
by Cornely, Oliver A and Maertens, Johan and Winston, Drew J and Perfect, John and Ullmann, Andrew J and Walsh, Thomas J and Helfgott, David and Holowiecki, Jerzy and Stockelberg, Dick and Goh, Yeow-Tee and Petrini, Mario and Hardalo, Cathy and Suresh, Ramachandran and Angulo-Gonzalez, David
The New England journal of medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 4, pp. 348 - 359
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Single-Blind Method | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Fluconazole - adverse effects | Male | Opportunistic Infections - prevention & control | Leukemia, Myeloid, Acute - complications | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Antineoplastic Agents - adverse effects | Neutropenia - mortality | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Neutropenia - chemically induced | Myelodysplastic Syndromes - drug therapy | Triazoles - therapeutic use | Mycoses - prevention & control | Kaplan-Meier Estimate | Treatment Outcome | Myelodysplastic Syndromes - complications | Neutropenia - drug therapy | Itraconazole - therapeutic use | Leukemia, Myeloid, Acute - mortality | Itraconazole - adverse effects | Adolescent | Myelodysplastic Syndromes - mortality | Aged | Mycoses - mortality | Fluconazole | Comparative analysis | Fungi | Infections | Fungal infections | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights